Clinical trial
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney…
NCT00167791 · University of Wisconsin, Madison, Other · Withdrawn
Key facts
| NCT number | NCT00167791 |
|---|---|
| Title | Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant |
| Official title | Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | rituximab |
| Enrollment | 0 |
| Start date | Jul 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: